More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales ...

Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that ...

Thousand Oaks-based Amgen saw shares dip about 5% on Aug. 6, the day after the company’s earnings announcement, though not because of the earnings themselves but rather about news of its weight-loss ...

Amgen stock dropped Wednesday despite a strong second quarter as investors look ahead to the next weight-loss readouts.

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales ...

For Q2 2025, Aristotle Capital’s Value Equity Composite outperformed the Russell 1000 Value Index and underperformed the S&P 500 Index.

Amgen’s diversified portfolio strategy continues to hinge on a balance between high-margin legacy biologics, expanding biosimilar offerings, and innovative pipeline investments. Repatha and BLINCYTO ...

US Dollar South African Rand, Nasdaq 100, S&P 500, Intel Corporation. Read 's Market Analysis on Investing.com ZA.

Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.